Natera NTRA
$ 123.68
-0.39%
Annual report 2022
added 03-01-2023
Country |
USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Steven Chapman |
Employees in the company |
1 039 |
Shares |
98.4 M |
Market Cap[1] |
$ 12.2 B |
EBITDA (LTM) |
$ -460 M |
P/E (LTM) |
-11.3 |
P/S (LTM) |
10.18 |
EPS (LTM) |
-5.14 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.